A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor...

PLoS ONE 2019 / 9 Vol. 14; Iss. 9

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms

Wolin, Edward, Mita, Alain, Mahipal, Amit, Meyer, Tim, Bendell, Johanna, Nemunaitis, John, Munster, Pam N., Paz-Ares, Luis, Filvaroff, Ellen H., Li, Shaoyi, Hege, Kristen, de Haan, Hans, Mita, Monica,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0221994
Date:
September, 2019
File:
PDF, 1.13 MB
english, 2019
Conversion to is in progress
Conversion to is failed